Active Clinical Trials for Prostate Cancer

This page lists many active clinical trials (protocols) at Fox Chase Cancer Center for Prostate cancer. In addition to the title, some studies below have brief summaries.

Clinical trials, or protocols, are research studies conducted with people who volunteer to take part. You benefit by having access to new cancer treatments and options not otherwise available, in addition to the excellent care offered at Fox Chase.

For more information on clinical trials at Fox Chase Cancer Center, or to find a study, call 1-888 FOX CHASE (1-888-369-2427).
Open DateTrial NumberPrincipal InvestigatorTitle
02/27/2012IRB11825/11-825SUZANNE MILLER Randomized Controlled Trial Of An Online Multimedia Program To Boost Coping & Function For Prostate Cancer Survivors (PROGRESS - PRostate Cancer Online Guide & Resources For Electronic Survivorship Service)
09/13/2011IRB11845/11-845CAROLYN HECKMAN Intimacy-Enhancing Couples' Intervention For Localized Prostate Cancer
11/19/1996IRB96091/96-091ELIAS OBEID Development Of A Prostate Cancer Risk Assessment Program
01/17/2014IRB13864/13-864YU-NING WONG Treatment Preference And Patient Centered Prostate Cancer Care
12/10/2013IRB13846/13-846ELIAS OBEID Genetic Evaluation Of Men - The GEM Registry
09/02/2014TEMPLES1216/13-901ALVARO PEREIRA-RICO A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK700 With Androgen Deprivation Therapy + Bicalutamide In Patients With Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
09/18/2003IRB03835/03-835ERIC HORWITZ Prospective Collection Of Characteristics And Outcome Of Patients Treated For Prostate Cancer At Fox Chase Cancer Center
09/08/201515-1011/15-1011MARIJO BILUSIC A Phase 1-2 Dose-Escalation and Safety Study of ADXS31-142 Alone and of ADXS31-142 in Combination with Pembrolizumab (MK-3475) in Patients with Previously Treated Metastatic Castration-Resistant Prostate Cancer
05/15/201515-9018/15-9018MARC SMALDONE Pennsylvania Urologic Regional Collaborative
07/28/201515-9022/15-9022ERIC HORWITZ Short term complications in prostate brachytherapy, active surveillance, and prostatectomy.
08/05/2015IRB14832/14-832MICHAEL HALL Advancing Web-based Medical Record Access and Risk Evaluation for Cancer Patients--The AWARE study--
01/14/200908854/08-854ELIAS OBEID The role of genetic variants at chromosomal loci 8q and 17q in prostate cancer screening in African American men and men with a family history of prostate cancer
09/04/201515-1001/15-1001MARC SMALDONE A Prospective, Multi-Institutional, Randomized, Phase II Trial of Best Systemic Therapy (BST) or Best Systemic Therapy Plus Definitive Treatment (radiation or surgery) of the primary tumor in Metastatic (M1) Prostate Cancer
01/13/201515-9001/15-9001MARK HALLMAN Comparative effectiveness of different fractionation schemes for treatment of prostate cancer
11/16/2012IRB12861/12-861ELIAS OBEID Hereditary Cancer Syndromes In Families of Men with Prostate Cancer In A Genetic Counseling Setting
08/04/2014SURG-073/14-036NESTOR ESNAOLA A Randomized Controlled Trial Of Perioperative Risk Stratification And Risk-Based, Protocol-Driven Management In Patients Undergoing Major Cancer Surgery
08/01/2014MB062714/14-823MARIJO BILUSIC Molecular Profiling Of Outlier Responses At FCCC
04/22/2013CTSUS1216/13-701YU-NING WONG A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide In Patients With Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
10/22/2013ARN-509/13-015MARIJO BILUSIC A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study Of ARN-509 In Men With Non-Metastatic (M0) Castration-Resistant Prostate Cancer